Difficult to believe that BOT is the only play progressing clinical trials for derma based CBD applications........"Only 1 trial in dermatology(Botanix)"
"Botanix holds the exclusive rights to utilise Permetrex for all drugs that treat skin diseases".........."Permetrex™ technology enables superior delivery of cannabidiol"........
Seriously looking forward to seeing these trial results........and very much awaiting some positive news re the possible functionality of the antimicrobial BTX1801....
Difficult to believe that BOT is the only play progressing...
-
- There are more pages in this discussion • 178 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.010(2.78%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.0¢ | 33.5¢ | $2.103M | 6.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32406 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 234417 | 5 |
View Market Depth
| Last trade - 16.10pm 02/12/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
